As many as 12% of Americans are currently using GLP-1 medications such as Ozempic and Wegovy, according to one estimate.

By Mariam Sunny Jan 13 (Reuters) - The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential ...

This article was reviewed by Lynn Marie Morski, MD, JD Key Takeaways: Peptides are compounds made of amino acids linked by ...

Federal regulators are telling drugmakers to remove label warnings about potential suicidal thoughts and behaviors from their ...

The U.S. health regulator asked drugmakers today to remove warnings about a potential risk of suicidal thoughts from widely ...

The Food and Drug Administration (FDA) is seeking to remove suicide warnings from several popular weight-loss medications, ...

The U.S. health regulator on Tuesday asked drugmakers to remove label warnings about a potential risk of suicidal thoughts ...

The FDA said it wants suicide warnings to be taken off some popular weight-loss medications following a comprehensive safety ...

The US Food and Drug Administration found no increased risk of suicidal behavior or ideation linked to popular weight-loss ...

Federal health regulators say popular weight loss drugs like Wegovy and Zepbound do not increase the risk of suicidal ...

The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential ​risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli ...

The FDA has instructed Novo Nordisk and Eli Lilly to remove suicide risk warnings from their weight-loss medications after a ...